Centene (CNC) Stock
Fundamentals
Source: third-party data provider, as of October 9, 2026
Compare with CNC
Recent news

Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
CNC

Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3
Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3
CNC

UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
CNC

Are Investors Undervaluing Centene (CNC) Right Now?
Are Investors Undervaluing Centene (CNC) Right Now?
CNC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 51.41
- MACD 12/26/9
- -0.36
- EMA 9 of MACD
- -0.58
- MACD histogram
- 0.22
- SMA 50
- $64.81
- Price below SMA 50
- EMA 50
- $64.15
- Price above EMA 50
- SMA 200
- $53.30
- Price above SMA 200
- EMA 200
- $53.61
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 8, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 8 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.84 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
CNC

Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3
Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3
CNC

UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
CNC

Are Investors Undervaluing Centene (CNC) Right Now?
Are Investors Undervaluing Centene (CNC) Right Now?
CNC

Best Growth Stocks to Buy for October 1st
Best Growth Stocks to Buy for October 1st
CNC

5 Low P/B Stocks With Attractive Value and Strong Growth Potential
5 Low P/B Stocks With Attractive Value and Strong Growth Potential
CNC

Best Growth Stocks to Buy for September 29th
Best Growth Stocks to Buy for September 29th
CNC

Here's Why Centene (CNC) is a Strong Value Stock
Here's Why Centene (CNC) is a Strong Value Stock
CNC

Best Growth Stocks to Buy for September 24th
Best Growth Stocks to Buy for September 24th
CNC

Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
CNC
News tone: automated (AI) classification of the article's content, not a price prediction.
About Centene
Centene Corporation, a FORTUNE® 50 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Sarah M. London | CEO & Director | 1981 |
| Mr. Andrew Lynn Asher | Executive VP & CFO | 1969 |
| Ms. Susan R. Smith | Chief Operating Officer | 1976 |
| Mr. Christopher Andrew Koster | Executive VP, General Counsel & Secretary | 1965 |
| Ms. Tanya M. McNally | Senior VP & Chief People Officer | 1974 |
| Mr. Theodore Joseph Pienkos | Corporate Controller & Chief Accounting Officer | 1982 |
| Mr. Bradley Bolivar | Chief Information Officer | — |
| Ms. Jennifer Lynch Gilligan | Senior Vice President of Investor Relations | — |
| Ms. Ashlee Knuckey | Chief Risk, Ethics & Compliance Officer | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 9, 2026
Technical indicators
- RSI 14
- 51.41
- MACD 12/26/9
- -0.36
- EMA 9 of MACD
- -0.58
- MACD histogram
- 0.22
- SMA 50
- $64.81
- Price below SMA 50
- EMA 50
- $64.15
- Price above EMA 50
- SMA 200
- $53.30
- Price above SMA 200
- EMA 200
- $53.61
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 8, 2026. Technical data, not a recommendation.
Analyst views
8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $65.00
- Average
- $73.00
- High
- $80.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +12.9 | -0.5 | +17.4 | |||||||||
| 2022 | -5.9 | +7.4 | +1.3 | -5.8 | +3.0 | +4.2 | +7.8 | -2.7 | -14.7 | +6.4 | +1.3 | -4.4 |
| 2023 | -4.4 | -9.0 | -7.7 | +6.6 | -9.0 | +3.9 | +1.1 | -9.4 | +12.4 | -0.5 | +6.3 | -0.9 |
| 2024 | -2.0 | +4.2 | +0.6 | -6.0 | -0.9 | -6.8 | +17.7 | +1.2 | -6.2 | -15.8 | -5.5 | +0.9 |
| 2025 | +5.8 | -10.3 | +3.6 | -1.0 | -5.0 | -1.1 | -54.0 | +12.1 | +20.5 | -1.0 | +14.0 | +8.6 |
| 2026 | +3.7 | +4.9 | -26.6 | +58.1 | +11.7 | +3.5 | -9.0 | +0.9 | -4.8 | +5.8 |



